|
JMJD1C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.100070E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.655300E-03 |
| Normal-vs-Stage2 |
7.814100E-02 |
| Normal-vs-Stage3 |
2.369000E-01 |
| Normal-vs-Stage4 |
1.156020E-01 |
| Stage1-vs-Stage2 |
6.840400E-01 |
| Stage1-vs-Stage3 |
4.972000E-01 |
| Stage1-vs-Stage4 |
8.776800E-01 |
| Stage2-vs-Stage3 |
3.957400E-01 |
| Stage2-vs-Stage4 |
6.821600E-01 |
| Stage3-vs-Stage4 |
7.583600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.957700E-03 |
| Normal-vs-AfricanAmerican |
2.656800E-03 |
| Normal-vs-Asian |
7.903000E-01 |
| Caucasian-vs-AfricanAmerican |
2.841200E-01 |
| Caucasian-vs-Asian |
5.986800E-01 |
| AfricanAmerican-vs-Asian |
4.130800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.398500E-03 |
| Normal-vs-Female |
4.698100E-03 |
| Male-vs-Female |
6.618600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.302100E-02 |
| Normal-vs-Extreme_Weight |
2.267700E-02 |
| Normal-vs-Obese |
1.135890E-02 |
| Normal-vs-Extreme_Obese |
3.023400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.515400E-01 |
| Normal_Weight-vs-Obese |
7.663600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.847200E-01 |
| Extreme_Weight-vs-Obese |
7.732800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.273800E-01 |
| Obese-vs-Extreme_Obese |
5.912200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.472400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.8269299999929E-05 |
| Normal-vs-Age(61-80Yrs) |
1.057380E-01 |
| Normal-vs-Age(81-100Yrs) |
6.103600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.594200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.617150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.372800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.281780E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.229840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.416400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.65939999980425E-07 |
| Normal-VS-Type2 PRCC |
4.202000E-01 |
| Normal-VS-KIRP CIMP |
8.499400E-01 |
| Normal-VS-Unclassified PRCC |
3.219700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.16829999510892E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.768300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.937400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.791400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.302800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.000300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.084000E-01 |
| Normal-vs-N1 |
1.839860E-02 |
| Normal-vs-N2 |
9.714400E-01 |
| N0-vs-N1 |
5.288000E-02 |
| N0-vs-N2 |
8.351600E-01 |
| N1-vs-N2 |
2.951800E-01 |
|
|
